Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutralizing Antibodies”

184 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 184 results

Not applicableStudy completedNCT00336557
What this trial is testing

Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,230
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Testing effectiveness (Phase 2)UnknownNCT03625934
What this trial is testing

Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001

Who this might be right for
Hepatitis B
Viravaxx AG 84
Not applicableUnknownNCT05618275
What this trial is testing

Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS

Who this might be right for
BK Virus Infection
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)UnknownNCT04838821
What this trial is testing

Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients

Who this might be right for
Covid19
Caja Costarricense de Seguro Social 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT04983030
What this trial is testing

Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults

Who this might be right for
HIVAcquired Immunodeficiency SyndromeImmunologic Deficiency Syndrome, Acquired+2 more
Boris Juelg, MD PhD 36
Testing effectiveness (Phase 2)Study completedNCT02446847
What this trial is testing

3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

Who this might be right for
HIV-1 Infection
Rockefeller University 16
Not applicableStudy completedNCT05057936
What this trial is testing

Antibody After COVID-19 Vaccination

Who this might be right for
Covid19Breakthrough InfectionCKD+2 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 140
Testing effectiveness (Phase 2)Study completedNCT01169844
What this trial is testing

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)UnknownNCT03719664
What this trial is testing

Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects

Who this might be right for
HIV-1-infection
Frontier Biotechnologies Inc. 80
Testing effectiveness (Phase 2)Study completedNCT02850016
What this trial is testing

Romidepsin Plus 3BNC117 Phase 2a Study

Who this might be right for
Human Immunodeficiency Virus (HIV)
Rockefeller University 48
Not applicableUnknownNCT05484700
What this trial is testing

Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms

Who this might be right for
Long COVID-19
Mahidol University 305
Testing effectiveness (Phase 2)Study completedNCT00077922
What this trial is testing

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphocyticChronic
National Cancer Institute (NCI) 15
Very early researchStudy completedNCT05110495
What this trial is testing

IGF Inhibition With Xentuzumab Prior to Radical Prostatectomy

Who this might be right for
Prostate Cancer
University of Oxford 27
Early research (Phase 1)UnknownNCT06050460
What this trial is testing

SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT03721510
What this trial is testing

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV/AIDS
International AIDS Vaccine Initiative 19
Not applicableUnknownNCT05087277
What this trial is testing

Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain

Who this might be right for
COVID-19
Centers for Disease Control and Prevention, China 150
Not applicableUnknownNCT05827939
What this trial is testing

Association of Phenotypic Age and Antibody Titers Among SARS-Co-V2 Infected Patients and Vaccinated Groups

Who this might be right for
COVID-19
Chang Gung Memorial Hospital 330
Testing effectiveness (Phase 2)Study completedNCT03041012
What this trial is testing

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Who this might be right for
Hiv
Aarhus University Hospital 60
Not applicableStudy completedNCT06891170
What this trial is testing

B Cell Responses in COVID-19

Who this might be right for
COVID 19
Fondazione IRCCS Policlinico San Matteo di Pavia 4
Load More Results